Professor Abraham Zangen is the head of the brain stimulation and behavior lab in the department of Life Sciences at the Ben-Gurion University in Israel. His research is directed to identification and understanding of altered neuroplasticity in psychiatric disorders - primarily depression, addiction and ADHD. He studies the effects of repeated brain stimulation on markers for neuroplasticity and on behavioral outcomes in psychiatric patients as well as in animal models for depression and addiction. He has developed unique deep transcranial magnetic stimulation coils for the treatments of depression, addiction and ADHD. The device he has developed for the treatment of depression was already approved by the FDA and other regulatory bodies, while other versions of his device are being tested for their efficacy in other psychiatric and neurological disorders. His early work in this field led to establishment of Brainsway, a company that commercializes the coils he developed with his colleagues. Prof. Zangen has published over 100 peer reviewed articles, reviews and book chapters. He has been was rewarded with numerous personal prizes for his scientific achievements including the Medical Futures Innovation Award in London, The Juludan Prize at the Technion, and received several distinguished research grants including NIH, H2020 and ISF funding.